396 related articles for article (PubMed ID: 23899693)
1. Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis.
Guo Y; Chan KH; Lai WH; Siu CW; Kwan SC; Tse HF; Wing-Lok Ho P; Wing-Man Ho J
Neuroimmunomodulation; 2013; 20(5):294-303. PubMed ID: 23899693
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis.
Guo Y; Chung SK; Siu CW; Kwan SC; Ho PW; Yeung PK; Chan KH
J Neuroimmunol; 2014 Nov; 276(1-2):64-70. PubMed ID: 25205217
[TBL] [Abstract][Full Text] [Related]
3. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells.
Jin G; Hamaguchi Y; Matsushita T; Hasegawa M; Le Huu D; Ishiura N; Naka K; Hirao A; Takehara K; Fujimoto M
J Allergy Clin Immunol; 2013 Jun; 131(6):1674-82. PubMed ID: 23534976
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis.
Begum-Haque S; Sharma A; Christy M; Lentini T; Ochoa-Reparaz J; Fayed IF; Mielcarz D; Haque A; Kasper LH
J Neuroimmunol; 2010 Feb; 219(1-2):47-53. PubMed ID: 20034680
[TBL] [Abstract][Full Text] [Related]
5. Treatment of an autoimmune encephalomyelitis mouse model with nonmyeloablative conditioning and syngeneic bone marrow transplantation.
Meng L; Ouyang J; Zhang H; Wen Y; Chen J; Zhou J
Restor Neurol Neurosci; 2011; 29(3):177-85. PubMed ID: 21586824
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.
Lu Z; Hu X; Zhu C; Wang D; Zheng X; Liu Q
J Neuroimmunol; 2009 Jan; 206(1-2):58-69. PubMed ID: 19081144
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis.
Wang D; Li SP; Fu JS; Bai L; Guo L
Int J Dev Neurosci; 2016 Apr; 49():60-6. PubMed ID: 26827767
[TBL] [Abstract][Full Text] [Related]
8. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effect of allogenic bone marrow mesenchymal stem cell transplantation on EAE mouse].
Liu P; Xuan X; Zhu J; Guan S; Du Y; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):798-801. PubMed ID: 23948402
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
11. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
Ge Z; Da Y; Xue Z; Zhang K; Zhuang H; Peng M; Li Y; Li W; Simard A; Hao J; Yao Z; Zhang R
Exp Neurol; 2013 Mar; 241():56-66. PubMed ID: 23261766
[TBL] [Abstract][Full Text] [Related]
12. Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE).
Yousefi F; Ebtekar M; Soleimani M; Soudi S; Hashemi SM
Int Immunopharmacol; 2013 Nov; 17(3):608-16. PubMed ID: 23973288
[TBL] [Abstract][Full Text] [Related]
13. B cells are required for sunlight protection of mice from a CNS-targeted autoimmune attack.
Kok LF; Marsh-Wakefield F; Marshall JE; Gillis C; Halliday GM; Byrne SN
J Autoimmun; 2016 Sep; 73():10-23. PubMed ID: 27289166
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NADPH oxidase activation reduces EAE-induced white matter damage in mice.
Choi BY; Kim JH; Kho AR; Kim IY; Lee SH; Lee BE; Choi E; Sohn M; Stevenson M; Chung TN; Kauppinen TM; Suh SW
J Neuroinflammation; 2015 May; 12():104. PubMed ID: 26017142
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
[TBL] [Abstract][Full Text] [Related]
16. 2-BFI ameliorates EAE-induced mouse spinal cord damage: effective therapeutic time window and possible mechanisms.
Li F; Zhang ZX; Liu YF; Xu HQ; Hou ST; Zheng RY
Brain Res; 2012 Nov; 1483():13-9. PubMed ID: 22985669
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
Kassis I; Petrou P; Halimi M; Karussis D
Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
19. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R
J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
[TBL] [Abstract][Full Text] [Related]
20. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
